S
Stuart M. Cobbe
Researcher at University of Glasgow
Publications - 215
Citations - 31173
Stuart M. Cobbe is an academic researcher from University of Glasgow. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 64, co-authored 214 publications receiving 30218 citations. Previous affiliations of Stuart M. Cobbe include British Heart Foundation & Glasgow Royal Infirmary.
Papers
More filters
Journal ArticleDOI
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
J. Shepherd,Stuart M. Cobbe,Ian Ford,C. G. Isles,AR Lorimer,Peter W. Macfarlane,J. H. Mckillop,Christopher J. Packard +7 more
TL;DR: Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.
Journal ArticleDOI
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
James Shepherd,Gerard J. Blauw,Michael B. Murphy,Edward L.E.M. Bollen,Brendan M. Buckley,Stuart M. Cobbe,Ian Ford,Allan Gaw,Michael E. Hyland,J. Wouter Jukema,Adriaan M. Kamper,Peter W. Macfarlane,A. Edo Meinders,John Norrie,Chris J. Packard,Ivan J. Perry,David J. Stott,Brian Sweeney,Gillian Twomey,Rudi G. J. Westendorp +19 more
TL;DR: Pravastatin given for 3 years reduced the risk of coronary disease in elderly individuals and was extended to elderly individuals the treatment strategy currently used in middle aged people.
Journal ArticleDOI
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
Bengt Fellström,Alan G. Jardine,Roland E. Schmieder,Hallvard Holdaas,Kym M. Bannister,J.J. Beutler,Dong Wan Chae,Alejandro Chevaile,Stuart M. Cobbe,Carola Grönhagen-Riska,José Jayme Galvão de Lima,Robert L. Lins,Gert Mayer,Alan W. McMahon,Hans-Henrik Parving,Hans-Henrik Parving,Giuseppe Remuzzi,Ola Samuelsson,Sandor Sonkodi,Gultekin Suleymanlar,Dimitrios Tsakiris,Vladimir Tesar,Vasil Todorov,Andrzej Wiecek,Rudolf P. Wüthrich,Mattis Gottlow,Eva Johnsson,Faiez Zannad +27 more
TL;DR: In patients undergoing hemodialysis, the initiation of treatment with rosuvastatin lowered the LDL cholesterol level but had no significant effect on the composite primary end point of death from cardiovascular causes, nonf fatal myocardial infarction, or nonfatal stroke.
Journal ArticleDOI
West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials
J. Shepherd,Stuart M. Cobbe,AR Lorimer,James H. McKillop,Jane B. Ford,Christopher J. Packard,Peter W. Macfarlane,Chris Isles,MF Oliver,A. F. Lever,BW Brown,Jgg Ledingham,SJ Pocock,BM Rifkind,B. D. Vallance,David Ballantyne,L Anderson,D Duncan,Sharon Kean,A Lawrence,John J. McGrath,K Montgomery,John Norrie,M Percy,E Pomphrey,Andrew J. O. Whitehouse,Peter Cameron,P Parker,F Porteous,L Fletcher,C Kilday,D Shoat,S Latif,James L. Kennedy,M A Bell,R Birrell,M Mellies,J Meyer,W Campbell +38 more
Journal ArticleDOI
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Naveed Sattar,Allan Gaw,Olga Scherbakova,Ian Ford,Denis St. J. O’Reilly,Steven M. Haffner,Chris Isles,Peter W. Macfarlane,Chris J. Packard,Stuart M. Cobbe,James Shepherd +10 more
TL;DR: A modified NCEP metabolic syndrome definition predicts CHD events, and, more strikingly, new-onset diabetes, and thus helps identify individuals who may receive particular benefit from lifestyle measures to prevent these diseases.